GlassScriptPhysician profile
Nathan James Powell
NPI 1669659439
$21,560.65
in general payments reported to CMS, 2019-2025
19 companies · $2,172 in 2025
The $2,172 reported for 2025 was more than what 80% of Surgical Critical Care providers received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,293 · 2020: $1,936 · 2021: $5,647 · 2022: $789 · 2023: $7,613 · 2024: $112 · 2025: $2,172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,000 · Travel and Lodging: $2,928 · Food and Beverage: $968.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,000.00 |
| Travel and Lodging | $2,928.07 |
| Food and Beverage | $968.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $16,008.89 | 2020-2025 | Davinci Xi, Da Vinci Surgical System |
| Allergan, INC. | $4,294.44 | 2019-2022 | |
| Tela Bio, INC. | $243.18 | 2019-2022 | |
| Kci USA, INC. | $172.48 | 2019-2023 | Abthera Advance |
| Davol INC. | $141.15 | 2020-2024 | Phasix Mesh |
| Abbvie INC. | $97.14 | 2023 | |
| Prytime Medical Devices, INC. | $93.61 | 2019 | |
| Depuy Synthes Sales INC. | $73.40 | 2025 | |
| Atricure, INC. | $64.85 | 2022-2023 | |
| Polynovo North America LLC | $57.57 | 2022-2025 | Novosorb Btm |
| Medtronic, INC. | $55.72 | 2022 | |
| Integra Lifesciences Corporation | $55.53 | 2020 | |
| Aroa Biosurgery Incorporated | $37.87 | 2025 | |
| Tei Biosciences INC | $34.37 | 2019 | |
| Kls-Martin L.P. | $30.99 | 2019-2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ambu INC. | $28.24 | 2022 | |
| Ethicon US, LLC | $27.16 | 2025 | Harmonic, Vistaseal |
| Organogenesis INC. | $24.77 | 2022 | |
| Solventum Corporation | $19.29 | 2024 | Prevena, Abthera, V.A.C. Veraflo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Powell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.